Back

Annenberg Center for Health Sciences at Eisenhower

  • Hematologic Neoplasms
  • Immunotherapy, Adoptive

Interprofessional Care of Patients Treated with CAR T-Cell Therapy

Chimeric antigen receptor (CAR) T-cell therapies have transformed patient outcomes and treatment approaches for patients with difficult-to-treat hematologic malignancies leading to improved overall survival. However, the use of CAR T-cell therapies is challenging, requiring careful patient selection, prolonged treatment at an authorized treatment center, and ongoing monitoring and support provided by an interprofessional, multidisciplinary care team in the community and treatment center settings. This activity highlights key concepts in managing patients treated with CAR T-cell therapy, provides an overview of the principles of interprofessional collaboration, and describes the importance of close communication and collaboration, particularly during the transition from treatment center back to the community setting.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 0.25 creditsAMA PRA Category 1 Credit™Up to 0.25 creditsNursingUp to 0.25 creditsPharmacyUp to 0.25 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.25 credits
  • Released
    Feb 5, 2026
  • Last day to claim credit
    Feb 6, 2027 4 months left